Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 3,088 | 6,859 | 4,633 | 6,705 | 3,346 |
| Cost of Goods | N/A | N/A | N/A | 41 | 37 |
| Gross Profit | 3,088 | 6,859 | 4,633 | 6,664 | 3,309 |
| Operating Expenses | 21,953 | 20,441 | 16,367 | 21,137 | 27,907 |
| Operating Income | -18,865 | -13,582 | -11,734 | -14,432 | -24,561 |
| Other Income | 768 | 379 | 240 | 603 | 1,808 |
| Pre-tax Income | -18,097 | -13,204 | -11,494 | -13,829 | -22,753 |
| Net Income Continuous | -18,097 | -13,204 | -11,494 | -13,829 | -22,753 |
| Net Income | $-18,097 | $-13,204 | $-12,670 | $-13,829 | $-22,753 |
| EPS Basic Total Ops | -43.93 | -32.40 | -36.00 | -41.40 | -70.19 |
| EPS Basic Continuous Ops | -43.91 | -32.57 | -32.40 | -41.40 | -70.19 |
| EPS Diluted Total Ops | -43.93 | -32.40 | -36.00 | -41.40 | -70.19 |
| EPS Diluted Continuous Ops | -43.91 | -32.57 | -32.40 | -41.40 | -70.19 |
| EBITDA(a) | $-17,273 | $-12,194 | $-10,207 | $-12,810 | $-22,304 |